$IVST Across our business segments, Innovest has been integrating operations and streamlining business processes to position the Company for sales growth and increased margins in 2020. Our first half year 2019 results were strong at $30.2 million, over 20% ahead of year to date 2019 guidance (click here for guidance). Innovest continues to achieve success across all segments through increased order pipelines and targets, new customer orders and positive customer implementations all of which position the Company for continued future growth.

https://www.businesswire.com/news/home/201909...on-Biotech